A Doctor has filed a lawsuit against the DEA  for denying him permission to use psilocybin therapy in his palliative care. His team believes they are violating the humanitarian Right to Try for terminally ill patients. Today we invite Dr. Aggarwal, his patient Erinn Baldeschwiler and their lawyer, Kathryn Tucker J.D., to frame this unique and pivotal case against the DEA.  Topics CoveredPsilocybin psychotherapy for terminal patients Integrative approaches in palliative care, and why practitioners are reaching for psychedelics Ketamine psychotherapyLegal stance on psilocybin in the United States as of March 2021The Right To Try Act — what it means, who and what is eligible, and a brief history on it's impactA history of lawsuits against the DEA, specifically cannabisShow Notes FDA's Right to Try Act: https://fda.gov/RTTAct Donate to the Nowak Society: https://www.thenowaksociety.org/projectsEmerge Law Group: https://emergelawgroup.com/2017/Cannabis' legal history: https://thehia.org/Hemp-Legal-HIA-vs-DEADr. Aggarwal's website: http://www.cannabinologist.org/AIMS Institute: https://www.aimsinstitute.net/